OTC pain relief gets a boost as the FDA approves an acetaminophen‑naproxen combo, offering a new over‑the‑counter option for adults and kids…
Discover key strategies from the 2026 Pharmacists Convention on policy and AI to enhance operations and outcomes for independent pharmacists.
Glucagon-like peptide-1 receptor agonist prevents pulmonary fibrosis in covid-19 patients with type 2 diabetes.
Isatuximab approval in the EU marks the first subcutaneous Sarclisa delivery via the CirCLIQ injector, expanding multiple myeloma treatment options across Europ
Step therapy for Vabysmo leads to treatment delays and higher costs for patients and eye‑care providers, highlighting the financial burden of step‑therapy…
The FTC settlement with Caremark and Zinc Health targets pharmacy benefit managers to lower insulin costs and improve transparency for consumers.
The U.S. Medicare drug pricing policy may cut costs by matching prices in other wealthy nations, reshaping pharmaceutical research priorities.